“IMFINZI® (durvalumab) is a doctor prescribed solution used to treat a sort of lung cancer called non-little cell lung cancer (NSCLC).
IMFINZI is utilized to treat a kind of lung malignancy called non-little cell lung disease (NSCLC) in grown-ups. It is utilized when your NSCLC: includes spread inside your lung and can’t be expelled by medical procedure, and
has reacted or balanced out after beginning treatment with chemotherapy and radiotherapy.
IMFINZI contains the dynamic substance durvalumab which is a monoclonal counter acting agent, a sort of protein intended to perceive a particular target substance in the body. IMFINZI works by helping your invulnerable framework battle your malignant growth.
In the event that you have any inquiries regarding how IMFINZI functions or why this prescription has been endorsed for you, ask your specialist or drug specialist.”